RORgammat inverse agonist 31 (14g) is a potent retinoic acid receptor-related orphan receptor gammat (RORgammat) inverse agonist, with an IC50 of 0.428 µM. RORgammat inverse agonist 31 can alleviate the severity of Imiquimod (HY-B0180)-induced psoriasis in mice[1].
Molecular Weight:
555.36
Formula:
C23H15Cl2F3N4O3S
Target:
ROR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted